The ovulation-inducing and LH, FSH and prolactin releasing activities of prostaglandin F
2α (PG F
2α) were investigated, using the female rats which had ovulation blocked by chlorpromazine (CPZ). Serum LH, FSH and prolactin concentrations were measured with NIAMD-rat-radioimmunoassay kits. The number of ova present in the fallopian tubes was investigated microscopically. Subcutaneous injection of 0.4-1.6mg of PG F
2α at 3:00 p.m. to CPZ-blocked proestrous rats induced ovulation in 80% of the animals during presumptive estrus. However, the percentage of ovulating rats was reduced in 40-60% of the animals when the same doses of P F
2α were injected intravenously. All control animals receiving the vehicle alone did not ovulated. The number of ova was not related to the dose of PG F
2α, but the percentage of ovulating rats was.
The serum LH peak was observed 10min after the intravenous injection and 60-180min after the subcutaneous injection of PG F
2α. The peak in serum FSH and prolactin occurred simultaneously 180min after both subcutaneous and intravenous injection of PG F
2α.
It is concluded from these data that PG F
2α, at dose levels used, may directly affect the hypothalamo-pituitary axis and consequently induce ovulation. These results further support the conception that the prostaglandins (PGs) have a central effect stimulating LH, FSH and prolactin release from the anterior pituitary.
View full abstract